REFERENCES
- European Pharmacopoeia. European Pharmacopoeia Commission, Strasbourg 2002
- Abeydeera L. R. In vitro production of embryos in swine. Theriogenology 2002; 57: 257–273, [CSA]
- Adam N., Ghosh P. Hyaluronan molecular weight and polydispersity in some commercial intra-articular injectable preparation and in synovial fluid. Inflamm. Res. 2001; 50: 294–299, [PUBMED], [INFOTRIEVE], [CSA]
- Adams M. E., Lussier A. J., Peyron J. G. A risk-benefit assessment of injections of hyaluronan and its derivatives in the treatment of osteoarthritis of the knee. Drug Saf. 2000; 23: 115–130, [PUBMED], [INFOTRIEVE], [CSA]
- Altman R. D. Intra-articular sodium hyaluronate in osteoarthritis of the knee. Semin. Arthritis Rheum. 2000; 30: 11–18, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Amr S. K. The effect of homogenised skin on the activity of licosamde antibiotics. Proc. Millen. Cong. Pharma. Sci. 2000; A80, [CSA]
- Armstrong S. E., Bell D. R. Measurement of high-molecular-weight hyaluronan in solid tissue using agarose gel electrophoresis. Anal. Biochem. 2002; 308: 255–264, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Arnott S., Mitra A. K., Raghunathan S. Hyaluronic-acid double helix. J. Mol. Biol. 1983; 169: 861–872, [PUBMED], [INFOTRIEVE], [CSA]
- Asteriou T., Deschrevel B., Delpech B., Bertrand P., Bultelle F., Merai C., Vincent J. C. An improved assay for the n-acetyl—glucosamine reducing ends of polysaccharides in the presence of proteins. Anal. Biochem. 2001; 293: 53–59, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Balazs E. A., Cowman M. K., Briller S. O. On limiting viscosity number of hyaluronate in potassium phosphate buffers between pH 6.5 and 8. Biopolymers 1983; 22: 589, [CSA], [CROSSREF]
- Balazs E. A. The viscoelastic intracellular matrix and control of cel function by hyaluronanl. The chemistry, Biology and Medical Applications of Hyaluronan and Its Derivatives, T. C. Laurent. Portland Press, London 1998; 185–204
- Balazs E. A. Analgesic effect of elastoviscous hyaluronan solutions and the treatment of arthritic pain. Cells Tissues Organs 2003; 174: 49–62, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Balazs E. A., Denlinger J. L. Clinical uses of hyaluronan. Ciba Foundation Symposia 1989; 143: 265–280, [PUBMED], [INFOTRIEVE], [CSA]
- Balazs E. A., Denlinger J. L. Viscosupplementation: a new concept in the treatment of osteoarthritis. J. Rheumatol. 1993; 20: 3–9, [CSA]
- Band P. A. Hyaluronan derivatives: chemistry and clinical applications. The Chemistry, Biology and Medical Applications of Hyaluronan and its derivatives, T. C. Laurent. Portland Press, London 1998; 33–42
- Banerji S., Ni J., Wang S. X., Clasper S., Su J., Tammi R., Jones M., Jackson D. G. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J. Cell Biol. 1999; 144: 789–801, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Banks J., Kreider J. W., Bhavanadan V. P., Davidson E. A. Anionic polysaccharide production and tyrosine activation in clutured human melanima cells. Cancer Res. 1976; 36: 424–431, [PUBMED], [INFOTRIEVE], [CSA]
- Barrett J. P., Siviero P. Retrospective study of outcomes in Hyalgan (R)-treated patients with osteoarthritis of the knee. Clin. Drug Invest. 2002; 22: 87–97, [CSA]
- Basedow A. M., Ebert K. Ultrasonic degradation of polymers in solution. Adv. Polymer Sci. 1977; 22: 83–148, [CSA]
- Beaty N. B. Relative molecular weight and concentration determination of sodium hyaluronate solutions by gel-exclusion high-performance liquid chromatography. Anal. Biochem. 1985; 147: 387–395, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Bernatchez S. F., Tabatabay C., Gurny R. Sodium hyaluronate 0.25-percent used as a vehicle increases the bioavailability of topically administered gentamicin. Graefes Arch. Clin. Exp. Ophthalmol. 1993; 231: 157–161, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Bitter T., Muir H. M. A modified uronic acid reaction. Anal. Biochem. 1962; 4: 330–334, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Blumberg B. S. Light-scattering studies on hyaluronic acid. Science 1954; 120: 432–433, [PUBMED], [INFOTRIEVE], [CSA]
- Braun D. P., Taylor S. G., Hams J. E. Modulation of immunity in cancer patients by prostaglandin antagonists. Immunity to Cancer II, R. Alan. Liss Inc, New York 1989; 439–448
- Brown M. B., Forbes B., Martin G. P. The use of hyaluronan in topical drug delivery. Hyaluronan: Biomedical, Medical and Clinical Aspects, J. Kennedy, G. O. Phillips, P. A. Williams, V. Hascall. Woodhead Publishers, Cambridge 2002; 249–256
- Brown M. B., Ingham S., Moore A., Marriott C., Martin G. P. A preliminary study of the effect of hyaluronan in drug delivery. Hyaluronan in Drug Delivery, D. A. Willoughby. Royal Society of Medicine Press, London 1995a; 48–52
- Brown M. B., Marriott C., Martin G. P. A study of the transdermal drug delivery properties of hyaluronan. Hyaluronan in Drug Delivery, D. A. Willoughby. Royal Society of Medicine Press, London 1995b; 53–71
- Brown M. B., Marriott C., Martin G. P. The effect of hyaluronan on the in vitro deposition of diclofenac within the skin. Int. J. Tissue Reactions—Exp. Clin. Aspects 1995c; 17: 133–140, [CSA]
- Brown M. B., Martin G. P. Comparison of the effect of hyaluronan and other polysaccharides on drug skin partitioning. Int. J. Pharm. 2001; 225: 113–121, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Brown M. B., Moore A. The effects of a novel formulation of cyclosporin on antibody and cell-mediated immune reactions in the pleural cavity of rats. Hyaluronan in Drug Delivery, D. A. Willoughby. Royal Society of Medicine Press, London 1996; 121–131
- Brown T. J., Alcorn D., Fraser J. R. E. Absorption of hyaluronan applied to the surface of intact skin. J. Invest. Dermatol. 1999; 113: 740–746, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Brunda M. J., Herberman R. B., Holden H. I. Inhibition of munne natural killer cell activity by prostaglandins. J. Immunol. 1980; 124: 2682–2687, [PUBMED], [INFOTRIEVE], [CSA]
- Bucolo C., Mangiafico P. Pharmacological profile of a new topical pilocarpine formulation. J. Ocul. Pharmacol. Ther. 1999; 15: 567–573, [PUBMED], [INFOTRIEVE], [CSA]
- Bucolo C., Spadaro A., Mangiafico S. Pharmacological evaluation of a new timolol/pilocarpine formulation. Ophthalmic Res. 1998; 30: 101–106, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Budiaman E. R., Fennema O. Linear rate of water crystallization as influenced by temperature of hydrocolloid suspensions. J. Dairy Sci. 1987; 70: 534–546, [CSA]
- Camber O., Edman P. Sodium hyaluronate as an ophthalmic vehicle—some factors governing its effect on the ocular absorption of pilocarpine. Curr. Eye Res. 1989; 8: 563–567, [PUBMED], [INFOTRIEVE], [CSA]
- Camber O., Edman P., Gurny R. Influence of sodium hyaluronate on the meiotic effect of pilocarpine in rabbits. Curr. Eye Res. 1987; 6: 779–784, [PUBMED], [INFOTRIEVE], [CSA]
- Campoccia D., Doherty P., Radice M., Brun P., Abatangelo G., Williams D. F. Semi-synthetic restorable materials from hyaluronan esterification. Biomaterials 1998; 19: 2101–2127, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Cantor J. O., Cerreta J. M., Armand G., Turino G. M. Aerosolized hyaluronic acid decreases alveolar injury induced by human neutrophil elastase. Proc. Soc. Exp. Biol. Med. 1998; 217: 471–475, [PUBMED], [INFOTRIEVE], [CSA]
- Castellano F., Mautone G. Decongestant activity of a new formulation of xylometazoline nasal spray: a double-blind, randomized versus placebo and reference drugs controlled, dose-effect study. Drugs Exp. Clin. Res. 2002; 28: 27–35, [PUBMED], [INFOTRIEVE], [CSA]
- Chaidedgumjorn A., Suzuki A., Toyoda H., Toida T., Imanari T., Linhardt R. J. Conductivity detection for molecular mass estimation of per-O-sulfonated glycosaminoglycans separated by high-performance size-exclusion chromatography. J. Chromatogr. A 2002; 959: 95–102, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Cichy J., Pure E. The liberation of CD44. J. Cell Biol. 2003; 161: 839–843, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Cleland R. L., Wang J. L. Ionic polysaccharides. III. Dilute solution properties of hyaluronic acid fractions. Biopolymers 1970; 9: 799, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Cowman M. K., Liu J., Hittner D. M., Kim J. S. Hyaluronan interactions: salt, water, ions'. The Chemistry, Biology and Medical Applications of Hyaluronan and Its Derivatives, T. C. Laurent. Portland Press, London 1998; 17–25
- Day A. J., Prestwich G. D. Hyaluronan-binding proteins: tying up the giant. J. Biol. Chem. 2002; 277: 4585–4588, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Day A. J., Sheehan J. K. Hyaluronan: polysaccharide chaos to protein organisation. Curr. Opin. Struct. Biol. 2001; 11: 617–622, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Del Rosso J. Q. New and emerging topical approaches for actinic keratoses. Cutis 2003; 72: 273, [PUBMED], [INFOTRIEVE], [CSA]
- Denlinger J. L. Hyaluronan and its derivatives as viscoelastics in medicine. The Chemistry, Biology and Medical Applications of Hyaluronan and Its Derivatives, T. C. Laurent. Portland Press, London 1998; 235–242
- Doherty M. M., Hughes P. J., Kim S. R., Mainwaring D. E., Charman W. N. Effect of lyophilization on the physical characteristics of medium molecular-mass hyaluronates. Int. J. Pharm. 1994; 111: 205–211, [CSA], [CROSSREF]
- Dougados M. Sodium hyaluronate therapy in osteoarthritis: arguments for a potential beneficial structural effect. Semin. Arth. Rheum. 2000; 30: 19–25, [CSA], [CROSSREF]
- Drobnik J. Hyaluronan in drug delivery. Adv. Drug Dev. Rev. 1991; 7: 295–308, [CSA], [CROSSREF]
- Durrani A. M., Farr S. J., Kellaway I. W. Influence of molecular-weight and formulation Ph on the precorneal clearance rate of hyaluronic-acid in the rabbit eye. Int. J. Pharm. 1995; 118: 243–250, [CSA], [CROSSREF]
- Eliaz R. E., Szoka F. C. Liposome-encapsulated doxorubicin targeted to CD44: a strategy to kill CD44-overexpressing tumor cells. Cancer Res. 2001; 61: 2592–2601, [PUBMED], [INFOTRIEVE], [CSA]
- Elliott G. R., Tak C., Pellens C., Ben-Efraim S., Bosta I. L. Indomethacin stimulation of macrophage cytostasis against MOPC 315 tumor cells is inhibited by both prostaglandin E2 and norhydroguaiaretic acid, a lipooxygenase inhibitor. Cancer Immun. Immunother. 1988; 27: 133–136, [CSA]
- Falk R. E., Mikkelsaar S., Asculai S., Bryant C., Veenstra J. Evaluation of prostaglandin (PGE) inhibitors combined with cytodestructive therapy in advanced neoplasia. Proc. Int. Clin. Hypertherm. Meeting. Loyon, Frrance, 1992
- Fieldman S. R., Fleischer A. B., McConnell C. Most common dermatological problems identified by internists. Arch. Intern. Med. 1998; 158: 726–730, [CSA], [CROSSREF]
- Figueiredo F., Jones G. M., Thouas G. A., Trounson A. O. The effect of extracellular matrix molecules on mouse preimplantation embryo development in vitro. Repro. Fert. Devel. 2002; 14: 443–451, [CSA], [CROSSREF]
- Fraser J. R. E., Brown T. J., Laurent T. C. Catabolism of hyaluronan. The Chemistry, Biology and Medical Applications of Hyaluronan and its Derivatives, T. C. Laurent. Portland Press, London 1998; 85–92
- Fraser J. R. E., Kimpton W. G., Pierscionek B. K., Cahill R. N. P. The kinetics of hyaluronan in normal and acutely inflamed synovial joints—observations with experimental arthritis in sheep. Semin. Arth. Rheum. 1993; 22: 9–17, [CSA]
- Fraser J. R. E., Laurent T. C., Laurent U. B. G. Hyaluronan: its nature, distribution, functions and turnover. J. Intern. Med. 1997; 242: 27–33, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Fujii K., Kawata M., Kobayashi Y., Okamoto A., Nishinari K. Effects of the addition of hyaluronate segments with different chain lengths on the viscoelasticity of hyaluronic acid solutions. Biopolymers 1996; 38: 583–591, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Furnus C. C., de Matos D. G., Martinez A. G. Effect of hyaluronic acid on development of in vitro produced bovine embryos. Theriogenology 1998; 49: 1489–1499, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Gandolfi S. A., Massari A., Orsoni J. G. Low-molecular-weight sodium hyaluronate in the treatment of bacterial corneal ulcers. Graefes Arch. Clin. Exp. Ophthalmol. 1992; 230: 20–23, [PUBMED], [INFOTRIEVE], [CSA]
- Gardner D. K., Lane M., Stevens J., Schoolcraft W. B. Changing the start temperature and cooling rate in a slow-freezing protocol increases human blastocyst viability. Fertil. Steril. 2003; 79: 407–410, [PUBMED], [INFOTRIEVE], [CSA]
- Gardner D. K., Rodriegez-Martinez H., Lane M. Fetal development after transfer is increased by replacing protein with the glycosaminoglycan hyaluronan for mouse embryo culture and transfer. Hum. Reprod. 1999; 14: 2575–2580, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ghosh P., Guidolin D. Potential mechanism of action of intra-articular hyaluronan therapy in osteoarthritis: Are the effects molecular weight dependent?. Semin. Arth. Rheum. 2002; 32: 10–37, [CSA], [CROSSREF]
- Ghosh P., Hutadilok N., Adam N., Lentini A. Interactions of hyaluronan (hyaluronic-acid) with phospholipids as determined by gel-permeation chromatography, multi-angle laser-light-scattering photometry and h-1-nmr spectroscopy. Int. J. Biol. Macromol. 1994; 16: 237–244, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ghosh S., Jassal M. Use of polysaccharide fibres for modem wound dressings. Ind. J. Fibre Textile Res. 2002; 27: 434–450, [CSA]
- Gibbs D. A., Merrill E. W., Smith K. A., Balazs E. A. Rheology of hyaluronic acid. Biopolymers 1968; 6: 777–791, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Goodison S., Urquidi V., Tarin D. CD44 cell adhesion molecules. J. Clin. Path.-Mol. Path. 1999; 52: 189–196, [CSA]
- Gribbon P., Heng B. C., Hardingham T. E. The molecular basis of the solution properties of hyaluronan investigated by confocal fluorescence recovery after photobleaching. Biophys. J. 1999; 77: 2210–2216, [PUBMED], [INFOTRIEVE], [CSA]
- Gribbon P., Heng B. C., Hardingham T. E. The analysis of intermolecular interactions in concentrated hyaluronan solutions suggest no evidence for chain-chain association. Biochem. J. 2000; 350: 329–335, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Grimshaw J., Kane A., Trocha-Grimshaw J., Douglas A., Chakravrthy U., Archer D. Electrophoresis 1994; 15: 936–940, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Guidolin D. D., Ronchetti I. P., Lini E., Guerra D., Frizziero L. Morphological analysis of articular cartilage biopsies from a randomized. Clinical study comparing the effects of 500-730 kDa sodium hyaluronate (Hyalgan (R)) and methylprednisolone acetate on primary osteoarthritis of the knee. Osteoarthr. Cartilage 2001; 9: 371–381, [CSA], [CROSSREF]
- Gura E., Huckel M., Muller P. J. Specific degradation of hyaluronic acid and its rheological properties. Polym. Degrad. Stab. 1998; 59: 297–302, [CSA], [CROSSREF]
- Gurny R., Ibrahim H., Aebi A., Buri P., Wilson C. G., Washington N., Edman P., Camber O. Design and evaluation of controlled release systems for the eye. J. Control. Rel. 1987; 6: 367–373, [CSA], [CROSSREF]
- Hamburger M. I., Lakhanpal S., Mooar P. A., Oster D. Intra-articular hyaluronans: a review of product-specific safety profiles. Semin. Arth. Rheum. 2003; 32: 296–309, [CSA], [CROSSREF]
- Hawkins C. L., Davies M. J. Direct detection and identification of radicals generated during the hydroxyl radical-induced degradation of hyaluronic acid and related materials. Free Radic. Biol. Med. 1996; 21: 275–290, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Herrero-Vanrell R., Fernandez-Carballido A., Frutos G., Cadorniga R. Enhancement of the mydriatic response to tropicamide by bioadhesive polymers. J. Ocul. Pharmacol. Ther. 2000; 16: 419–428, [PUBMED], [INFOTRIEVE], [CSA]
- Hochberg M. C. Role of intra-articular hyaluronic acid preparations in medical management of osteoarthritis of the knee. Semin. Arth. Rheum. 2000; 30: 2–10, [CSA], [CROSSREF]
- How M. J., Long V. J. W. Separation and fractionation of hyaluronic acid from humam synovial fluid on agrose gels. Clin. Chim. Acta 1969; 23: 251–256, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Inoue M., Katakami C. The effect of hyaluronic-acid on corneal epithelial-cell proliferation. Invest. Ophthal. Visual Sci. 1993; 34: 2313–2315, [CSA]
- Iqbal Z. Determination of molecular weight of hyaluronic acid in bovine vitreous humour and Healon by high performance gel permeation chromatography and its depolymerization with ascorbic acid. Pharm. World Sci. 1997; 19: 246–250, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Itano N., Kimata K. Mammalian hyaluronan synthases. Iubmb Life 2002; 54: 195–199, [PUBMED], [INFOTRIEVE], [CSA]
- Jaakma U., Zhang B. R., Larsson B., Niwa K., RodriguezMartinez H. Effects of sperm treatments on the in vitro development of bovine oocytes in semidefined and defined media. Theriogenology 1997; 48: 711–720, [CSA], [CROSSREF]
- Jackson C., Larsen B., McEwen C. Comparison of most probable peak values as measured for polymer distributions by MALDI mass spectrometry and by size exclusion chromatography. Anal. Chem. 1996; 68: 1303–1308, [CSA], [CROSSREF]
- Jang G., Lee B. C., Kang S. K., Hwang W. S. Effect of glycosaminoglycans on the preimplantation development of embryos derived from in vitro fertilization and somatic cell nuclear transfer. Repro. Fert. Devel. 2003; 15: 179–185, [CSA], [CROSSREF]
- Jarvinen K., Jarvinen T., Urtti A. Ocular absorption following topical delivery. Adv. Drug Dev. Rev. 1995; 16: 3–19, [CSA], [CROSSREF]
- Jarvis B., Figgitt D. P. Topical 3% diclofenac in 2.5% hyaluronic acid gel—a review of its use in patients with actinic keratoses. Am. J. Clini. Derm. 2003; 4: 203–213, [CSA]
- Joly T., Nibart M., Thibier M. Hyaluronic-acid as a substitute for proteins in the deep-freezing of embryos from mice and sheep—an in vitro investigation. Theriogenology 1992; 37: 473–480, [CSA], [CROSSREF]
- Juhlin L. Hyaluronan in skin. J. Intern. Med. 1997; 242: 61–66, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kakehi K. Hyaluronic acid: separation and biological implications. J. Chromat. 2003; 797: 347–355, [CSA], [CROSSREF]
- Kano K., Miyano T., Kato S. Effects of glycosaminoglycans on the development of in vitro matured and fertilized porcine oocytes to the blastocyst stage in vitro. Biol. Reprod. 1998; 58: 1226–1232, [PUBMED], [INFOTRIEVE], [CSA]
- Karamanos N. K., Hjerpe A. High-performance capillary electrophoretic analysis of hyaluronan in effusions from human malignant mesothelioma1. J. Chromat. B: Biomed. Sci. Appl. 1997; 697: 277–281, [CSA], [CROSSREF]
- Karim S. The determination of the viscosity-average molecular weight of hyaluronan by capillary viscosity. Hyaluronan in Drug Delivery-4th International Workshop, D. Willoughby. Royal Society of Medicine. Press, London 1996; 97–107
- Karim S., Brown M. B., Ingham S., Martin G. P., Marriott C. Rheological and molecular weight studies of hyaluronan. Eur. J. Pharm. Sci. 1996; 4: S175, [CSA], [CROSSREF]
- Karlsson G., Bergman R. Determination of the distribution of molecular masses of sodium hyaluronan by high-performance anion-exchange chromatography. J. Chromat. A. 2003; 986: 67–72, [CSA], [CROSSREF]
- Kaufmann J., Mohle K., Hofmann H. J., Arnold K. Molecular dynamics study of hyaluronic acid in water. Theochem—J. Mol. Struc. 1998; 422: 109–121, [CSA], [CROSSREF]
- Kaur I. P., Smitha R. Penetration enhancers and ocular bioadhesives: Two new avenues for ophthalmic drug delivery. Drug Dev. Ind. Pharm. 2002; 28: 353–369, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kelly M. A., Goldberg V. M., Healy W. L., Pagnano M. W., Hamburger M. I. Osteoarthritis and beyond: a consensus on the past, present, and future of hyaluronans in orthopedics. Orthopedics 2003; 26: 1064–1079, [PUBMED], [INFOTRIEVE], [CSA]
- Kemmann E. Creutzfeldt-Jakob disease (CJD) and assisted reproductive technology (ART)—quantification of risks as part of informed consent. Hum. Reprod. 1998; 13: 1777, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kim A., Checkla D. M., Dehazya P., Chen W. L. Characterization of DNA-hyaluronan matrix for sustained gene transfer. J. Control. Rel. 2003; 90: 81–95, [CSA], [CROSSREF]
- Kirwan J. Is there a place for intra-articular hyaluronate in osteoarthritis of the knee?. Knee 2001; 8: 93–101, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Knudson W., Chow G., Knudson C. B. CD44-mediated uptake and degradation of hyaluronan. Matrix Biol. 2002; 21: 15–23, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kobayashi Y., Okamoto A., Nishinari K. Viscoelasticity of hyaluronic-acid with different molecular weights. Biorheology 1994; 31: 235–244, [PUBMED], [INFOTRIEVE], [CSA]
- Koshiishi I., Horikoshi E., Imanari T. Quantification of hyaluronan and chondroitin/dermatan sulfates in the tissue sections on glass slides. Anal. Biochem. 1999; 267: 222–226, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Lane M., Maybach J. M., Hooper K., Hasler J. F., Gardner D. K. Cryo-survival and development of bovine blastocysts are enhanced by culture with recombinant albumin and hyaluronan. Mol. Reprod. Dev. 2003; 64: 70–78, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Langer K., Mutschler E., Lambrecht G., Mayer D., Troschau G., Stieneker F., Kreuter J. Methylmethacrylate sulfopropylmethacrylate copolymer nanoparticles for drug delivery—Part III: evaluation as drug delivery system for ophthalmic applications. Int. J. Pharm. 1997; 158: 219–231, [CSA], [CROSSREF]
- Lapcik L., Lapcik L., De Smedt S., Demester J., Chabrecek P. Hyaluronan: preparation, structure, properties, and applications. Chem. Rev. 1998; 98: 2663–2684, [PUBMED], [CSA], [CROSSREF]
- Larsen N. E., Balazs E. A. Drug delivery systems using hyaluronan and its derivatives. Adv. Drug Dev. Rev. 1991; 7: 279–293, [CSA], [CROSSREF]
- Laurent T. C., Gergely J. Light scattering studies on hyaluronic acid. J. Biol. Chem. 1955; 212: 36–40, [CSA]
- Laurent T. C. Fraction of hyaluronic acid: the polydispersity of hyaluronic acid from the bovine vitreous body. Biochim. Biophys. Acta 1960; 42: 476–485, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Laurent T. C. Structure of hyaluronic acid. Chemistry and the Molecular Biology of the Intracellular Matrix, E. A. Balazs. Academic Press, London 1970; 703–732
- Laurent T. C. An early look at macromolecular crowding. Biophys. Chem. 1995; 57: 7–14, [CSA], [CROSSREF]
- Laurent T. C., Fraser J. R. E. Hyaluronan. FASEB J. 1992; 6: 2397–2404, [PUBMED], [INFOTRIEVE], [CSA]
- Lebel L. Clearance of hyaluronan from the circulation. Adv. Drug Dev. Rev. 1991; 7: 221–235, [CSA]
- Lee H. G., Cowman M. K. An agarose gel electrophoretic method for analysis of hyaluronan molecular weight distribution. Ana. Biochem. 1994; 219: 278–287, [CSA]
- Lee J. Y., Spicer A. P. Hyaluronan: a multifunctional, megaDalton, stealth molecule. Curr. Opin. Cell Biol. 2000; 12: 581–586, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Lim S. T., Forbes B., Berry D. J., Martin G. P., Brown M. B. In vivo evaluation of novel hyaluronan/chitosan microparticulate delivery systems for the nasal delivery of gentamicin in rabbits. Int. J. Pharm. 2002; 231: 73–82, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Lim S. T., Martin G. P., Berry D. J., Brown M. B. Preparation and evaluation of the in vitro drug release properties and mucoadhesion of novel microspheres of hyaluronic acid and chitosan. J. Control. Rel. 2000; 66: 281–292, [CSA], [CROSSREF]
- Lin W., Maibach H. I. Percutaneous absorption of diclofenac in hyaluronic acid gel: in vitro study in human skin. Hyaluronan in Drug Delivery, D. Willoughby. R. S. M. Press, London 1996; 167–174
- Liu J., Cowman M. K. Thermal analysis of semi-dilute hyaluronan solutions. J. Thermal Anal. Calorimetry 2000; 59: 547–557, [CSA], [CROSSREF]
- Lowry K. M., Beavers E. M. Thermal-stability of sodium hyaluronate in aqueous-solution. J. Biomed. Mater. Res. 1994; 28: 1239–1244, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Luo Y., Prestwich G. D. Synthesis and selective cytotoxicity of a hyaluronic acid-antitumor bioconjugate. Bioconjug. Chem. 1999; 10: 755–763, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Luo Y., Ziebell M. R., Prestwich G. D. A hyaluronic acid-taxol antitumor bioconjugate targeted to cancer cells. Biomacromolecules 2000; 1: 208–218, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Mabuchi K., Obara T., Ikegami K., Yamaguchi T., Kanayama T. Molecular weight independence of the effect of additive hyaluronic acid on the lubricating characteristics in synovial joints with experimental deterioration. Clin. Biomech. 1999; 14: 352–356, [CSA], [CROSSREF]
- Maheu E., Ayral X., Dougados M. A hyaluronan preparation (500–730 kDa) in the treatment of osteoarthritis: a review of clinical trials with Hyalgan((R)). Int. J. Clin. Pract. 2002; 56: 804–813, [PUBMED], [INFOTRIEVE], [CSA]
- McEwan L. E., Smith J. G. Topical diclofenac/hyaluronan gel in the treatment of solar keratoses. Aust. J. Derm. 1997; 38: 187–189, [CSA]
- Mendichi R., Schieroni A. G., Grassi C., Re A. Characterisation of ultra-high molar mass hyaluronan: 1. Off-line static methods. Polymer 1998; 39: 6611–6620, [CSA], [CROSSREF]
- Menzel E. J., Farr C. Hyaluronidase and its substrate hyaluronan: biochemistry, biological activities and therapeutic uses. Cancer Lett. 1998; 131: 3–11, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Meyer L., Palmer J. The polysaccharide of the vitreous humour. Biol. Chem. 1934; 107: 629–634, [CSA]
- Milas M., Rinaudo M., Roure I., Al Assaf S., Phillips G. O., Williams P. A. Comparative rheological behavior of hyaluronan from bacterial and animal sources with cross-linked hyaluronan (hylan) in aqueous solution. Biopolymers 2001; 59: 191–204, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Miltner O., Schneider U., Siebert C. H., Niedhart C., Niethard F. U. Efficacy of intraarticular hyaluronic acid in patients with osteoarthritis—a prospective clinical trial. Osteoarth. Cartilage 2002; 10: 680–686, [CSA], [CROSSREF]
- Miyano T., Hirooka R. E., Kano K., Miyake M., Kusunoki H., Kato S. Effects of hyaluronic-acid on the development of 1-cell and 2-cell porcine embryos to the blastocyst stage in vitro. Theriogenology 1994; 41: 1299–1305, [CSA], [CROSSREF]
- Miyazaki T., Miyauchi S., Nakamura T., Takeshita S., Horie K. The effect of sodium hyaluronate on the growth of rabbit cornea epithelial cells in vitro. J. Ocul. Pharmacol. Ther. 1996; 12: 409–415, [PUBMED], [INFOTRIEVE], [CSA]
- Miyazaki T., Yomota C., Okada S. Change in molecular weight of hyaluronic acid during measurement with a cone-plate rotational viscometer. J. Appl. Polym. Sci. 1998; 67: 2199–2206, [CSA], [CROSSREF]
- Miyazaki T., Yomota C., Okada S. Hyaluronate depolymerization following thermal decomposition of oxytetracycline. Chem. Pharma. Bull. 2001; 49: 118–122, [CSA], [CROSSREF]
- Mo Y., Takaya T., Nishinari K., Kubota K., Okamoto A. Effects of sodium chloride, guanidine hydrochloride, and sucrose on the viscoelastic properties of sodium hyaluronate solutions. Biopolymers 1999; 50: 23–34, [CSA], [CROSSREF]
- Moreira C. A., Armstrong D. K., Jelliffe R. W., Moreira A. T., Woodford C. C., Liggett P. E., Trousdale M. D. Sodium hyaluronate as a carrier for intravitreal gentamicin—an experimental-study. Acta Ophthalmol. (Copenh). 1991a; 69: 45–49, [CSA]
- Moreira C. A., Moreira A. T., Armstrong D. K., Jelliffe R. W., Woodford C. C., Liggett P. E., Trousdale M. D. In vitro and in vivo studies with sodium hyaluronate as a carrier for intraocular gentamicin. Acta Ophthalmol. (Copenh). 1991b; 69: 50–56, [CSA]
- Moreland L. W. Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of action. Arth. Res. Ther. 2003; 5: 54–67, [CSA], [CROSSREF]
- Morimoto K., Metsugi K., Katsumata H., Iwanaga K., Kakemi M. Effects of low-viscosity sodium hyaluronate preparation on the pulmonary absorption of rh-insulin in rats. Drug Dev. Ind. Pharm. 2001; 27: 365–371, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Morimoto K., Yamaguchi H., Iwakura Y., Morisaka K., Ohashi Y., Nakai Y. Effects of viscous hyaluronate-sodium solutions on the nasal absorption of vasopressin and an analog. Pharm. Res. 1991; 8: 471–474, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Moy R. L. Clinical presentation of actinic keratoses and squamous cell carcinoma. J. Am. Acad. Dermatol. 2000; 42: S8–S10, [CSA], [CROSSREF]
- Nazir T., Martin G. P., Brown M. B. Dermal delivery of cyclosporin A entrapped liposomal gels—preformulation Franz cell diffusion studies using silastic membranes. Pharm. Sci. 2001; 3: 1429, suppl.[CSA]
- Ng C. K., Handley C. J., Preston B. N., Robinson H. C. The extracellular processing and catabolism of hyaluronan in cultured adult articular-cartilage explants. Arch. Biochem. Biophys. 1992; 298: 70–79, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ogston A. G., Stainer J. E. On the state of hyaluronic acid in synovial fluid. Biochem. J. 1950; 46: 364–376, [CSA]
- Ogston A. G., Stainer J. E. The dimension of the particle of hyaluronic acid complex in synovial fluid. Biochem. J. 1951; 49: 585–590, [PUBMED], [INFOTRIEVE], [CSA]
- Ogston A. G., Stainer J. E. Further observation on the preparation and compasition of the hyaluronic acid complex of ox synovial fluid. Biochem. J. 1952; 52: 149–156, [PUBMED], [INFOTRIEVE], [CSA]
- Ortonne J. P. A controlled study of the activity of hyaluronic acid in the treatment of venous leg ulcers. J. Dermat. Treat. 1996; 7: 75–81, [CSA]
- Panie W. R. Regression of head and neck carcinoma with a prostaglandin-synthesis inhibitor. Arch. Otolaryngol. 1981; 107: 658–663, [CSA]
- Pasquali Ronchetti I., Quaglino D., Mori G., Bacchelli B., Ghosh P. Hyaluronan-phospholipid interactions. J. Struct. Biol. 1997; 120: 1–10, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Peer D., Florentin A., Margalit R. Hyaluronan is a key component in cryoprotection and formulation of targeted unilamellar liposomes. Biochimi. Biophys. Acta-Biomemb. 2003; 1612: 76–82, [CSA], [CROSSREF]
- Peer D., Margalit R. Physicochemical evaluation of a stability-driven approach to drug entrapment in regular and in surface-modified liposomes. Arch. Biochem. Biophys. 2000; 383: 185–190, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Pigman W., Rizvi S., Holley H. Preparation and stability of hyaluronic acid. Biochim. Biophys. Acta-Biomemb. 1961; 46: 100, [CSA], [CROSSREF]
- Platzer M., Ozegowski J. H., Neubert R. H. H. Quantification of hyaluronan in pharmaceutical formulations using high performance capillary electrophoresis and the modified uronic acid carbazole reaction. J. Pharm. Biomed. Anal. 1999; 21: 491–496, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Poggi M. M., Klein M. B., Chapo G. A., Cuono C. B. Effects of cryopreservation and deconstruction on the dermal glycosaminoglycan content of human skin. J. Burn Care Rehab. 1999; 20: 201–206, [CSA]
- Ponta H., Sherman L., Herrlich P. A. CD44: from adhesion molecules to signalling regulators. Nat. Revi. Mol. Cell Biol. 2003; 4: 33–45, [CSA], [CROSSREF]
- Praest B. M. Assay of synovial fluid parameters: hyaluronan concentration as a potential marker for joint diseases. Clin. Chim. Acta. 1997; 266: 117–128, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Prevo R., Banerji S., Ferguson D. J. P., Clasper S., Jackson D. G. Mouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endothelium. J. Biol. Chem. 2001; 276: 19420–19430, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Prisell P. T., Camber O., Hiselius J., Norstedt G. Evaluation of hyaluronan as a vehicle for peptide growth factors. Int. J. Pharm. 1992; 85: 51–56, [CSA], [CROSSREF]
- Pritchard K., Lansley A. B., Martin G. P., Helliwell M., Marriott C., Benedetti L. M. Evaluation of the bioadhesive properties of hyaluronan derivatives: detachment weight and mucociliary transport rate studies. Int. J. Pharm. 1996; 129: 137–145, [CSA], [CROSSREF]
- Reed C. E. L. The effects of pH on hyaluronate as observed by light scattering. Biopolymers 1989; 28: 1981–2000, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Reed C. E., Reed W. F. Light-scattering power of randomly cut random coils with application to the determination of depolymerization rates. J. Chem. Phys. 1989; 91: 7193–7199, [CSA], [CROSSREF]
- Risberg B. Adhesions: preventive strategies. Eur. J. Surg. 1997; 163: 32–39, [CSA]
- Saettone M. F., Chetoni P., Torracca M. T., Burgalassi S., Giannaccini B. Evaluation of muco-adhesive properties and in vivo activity of ophthalmic vehicles based on hyaluronic-acid. Int. J. Pharm. 1989; 51: 203–212, [CSA], [CROSSREF]
- Saettone M. F., Giannaccini B., Chetoni P., Torracca M. T., Monti D. Evaluation of high-molecular-weight and low-molecular-weight fractions of sodium hyaluronate and an ionic complex as adjuvants for topical ophthalmic vehicles containing pilocarpine. Int. J. Pharm. 1991; 72: 131–139, [CSA], [CROSSREF]
- Saettone M. F., Monti D., Torracca M. T., Chetoni P. Mucoadhesive ophthalmic vehicles—evaluation of polymeric low-viscosity formulations. J. Ocul. Pharmacol. 1994; 10: 83–92, [PUBMED], [INFOTRIEVE], [CSA]
- Sakai S., Yasuda R., Sayo T., Ishikawa O., Inoue S. Hyaluronan exists in the normal stratum corneum. J. Invest. Dermatol. 2000; 114: 1184–1187, [PUBMED], [INFOTRIEVE], [CSA]
- Sakurai K., Andoh M., Yamada M., Kodera Y., Nishimura H., Hiroto M., Matsushima A., Aoyama M., Yamamoto H., Inada Y. Suppression of ischemic edema in mice by manganese-hyaluronate conjugate. Jpn. J. Pharmacol. 1997a; 74: 117–120, [PUBMED], [INFOTRIEVE], [CSA]
- Sakurai K., Miyazaki K., Kodera Y., Nishimura H., Shingu M., Inada Y. Anti-inflammatory activity of superoxide dismutase conjugated with sodium hyaluronate. Glycoconj. J. 1997b; 14: 723–728, [PUBMED], [INFOTRIEVE], [CSA]
- Sasaki H., Yamamura K., Nishida K., Nakamura J., Ichikawa M. Delivery of drugs to the eye by topical application. Prog. Retin. Eye Res. 1996; 15: 583–620, [CSA]
- Schartz R. A. The actinic keratoses. A perspective and update. Dermatol. Surg. 1997; 23: 1009–1019, [CSA]
- Scott J. E. The periphery of the developing collagen fibril—quantitative relationships with dermatan sulfate and other surface-associated species. Biochem. J. 1984; 218: 229–233, [PUBMED], [INFOTRIEVE], [CSA]
- Scott J. E., Heatley F. Hyaluronan forms specific stable tertiary structures in aqueous solution: a C-13 NMR study. Proc. Natl. Acad. Sci. USA 1999; 96: 4850–4855, [PUBMED], [INFOTRIEVE], [CSA]
- Scott J. E., Heatley F. Biological properties of hyaluronan in aqueous solution are controlled and sequestered by reversible tertiary structures, defined by NMR spectroscopy. Biomacromolecules 2002; 3: 547–553, [PUBMED], [INFOTRIEVE], [CSA]
- Seno N., Anno K., Kondo S., Nagase S., Saito S. Improved method for electrophoretic separation and rapid quantitation of isomeric chondroitin sulfates on cellulose acetate strips. Anal. Biochem. 1970; 1970: 197–202, [CSA]
- Sheehan J. K., Arundel C., Phelps C. F. Effect of the cations sodium, potassium and calcium on the interaction of hyaluronate chains—a light-scattering and viscometric study. Int. J. Biol. Macromol. 1983; 5: 222–228, [CSA]
- Shimada E., Matsumura G. Viscosity and molecular weight of hyaluronic acids. J. Biochem. 1975; 78: 513–517, [PUBMED], [INFOTRIEVE], [CSA]
- Shinomiya K., Hoshi Y., Imanari T. Sensitive detection of unsaturated disaccharides from chondroitin sulfates by thin-layer chromatography as their dansylhydrazine derivatives. J. Chromatogr. 1989; 462: 471–474, [PUBMED], [INFOTRIEVE], [CSA]
- Simon A., Safran A., Revel A., Aizenman E., Reubinoff B., Porat-Katz A., Lewin A., Laufer N. Hyaluronic acid can successfully replace albumin as the sole macromolecule in a human embryo transfer medium. Fertil. Steril. 2003; 79: 1434–1438, [PUBMED], [INFOTRIEVE], [CSA]
- Soldati D., Rahm F., Pasche P. Mucosal wound healing after nasal surgery. A controlled clinical trial on the efficacy of hyaluronic acid containing cream. Drugs Exp. Clin. Res. 1999; 25: 253–261, [PUBMED], [INFOTRIEVE], [CSA]
- Spicer A. P., Nguyen T. K. Mammalian hyaluronan synthases: investigation of functional relationships in vivo. Biochem. Soc. Trans. 1999; 27: 109–115, [PUBMED], [INFOTRIEVE], [CSA]
- Stiebel-Kalish H., Gaton D. D., Weinberger D., Loya N., Schwartz-Ventik M., Solomon A. A comparison of the effect of hyaluronic acid versus gentamicin on corneal epithelial healing. Eye 1998; 12: 829–833, [PUBMED], [INFOTRIEVE], [CSA]
- Suchanek E., Simunic V., Juretic D., Grizelj V. Follicular-fluid contents of hyaluronic-acid, follicle-stimulating-hormone and steroids relative to the success of in-vitro fertilization of human oocytes. Fertil. Steril. 1994; 62: 347–352, [PUBMED], [INFOTRIEVE], [CSA]
- Sundblad L. Glycosaminoglycans and glycoproteins in synovial fluid. The Amino Sugars. The Chemistry and Biology of the Compounds Containing the Amino Sugars, E. A. Balazs, R. W. Jeanloz. Academic Press, New York 1965; 229–250
- Surendrakumar K., Martyn G. P., Hodgers E. C. M., Jansen M., Blair J. A. Sustained release of insulin from sodium hyaluronate based dry powder formulations after pulmonary delivery to beagle dogs. J. Control. Rel. 2003; 91: 385–394, [CSA]
- Surini S., Akiyama H., Morishita M., Nagai T., Takayama K. Release phenomena of insulin from an implantable device composed of a polyion complex of chitosan and sodium hyaluronate. J. Control. Rel. 2003a; 90: 291–301, [CSA]
- Surini S., Akiyama H., Morishita M., Takayama K., Nagai T. Polyion complex of chitosan and sodium hyaluronate as an implant device for insulin delivery. Stp Pharma Sciences 2003b; 13: 265–268, [CSA]
- Takayama K., Hirata M., Machida Y., Masada T., Sannan T., Nagai T. Effect of interpolymer complex-formation on bioadhesive property and drug release phenomenon of compressed tablet consisting of chitosan and sodium hyaluronate. Chemi. Pharm. Bull. 1990; 38: 1993–1997, [CSA]
- Tammi M. I., Day A. J., Turley E. A. Hyaluronan and homeostasis: a balancing act. J. Biol. Chem. 2002; 277: 4581–4584, [PUBMED], [INFOTRIEVE], [CSA]
- Tammi R., Agren U. M., Tuhkanen A. L., Tammi M. Hyaluronan metabolism in skin—introduction. Hyaluronan Metabol. in Skin 1994; 29: 1–77, [CSA]
- Tammi R., Saamanen A. M., Maibach H. I., Tammi M. Degradation of newly synthesized high molecular mass hyaluronan in the epidermal and dermal compartments of human skin in organ culture. J. Invest. Dermatol. 1991; 97: 126–130, [PUBMED], [INFOTRIEVE], [CSA]
- Tani E., Katakami C., Negi A. Effects of various eye drops on corneal wound healing after superficial keratectomy in rabbits. Jpn. J. Ophthal. 2002; 46: 488–495, [CSA]
- Tascioglu F., Oner C. Efficacy of intra-articular sodium hyaluronate in the treatment of knee osteoarthritis. Clin. Rheumatol. 2003; 22: 112–117, [CSA]
- Tilden A. B., Balch C. M. Immune modulatory effects of indomethacin in melanoma are not related to prostaglandin E2-mediated suppression. Surgery 1982; 92: 528, [PUBMED], [INFOTRIEVE], [CSA]
- Toida T., Shima M., Azumaya S., Maruyama T., Toyoda H., Imanari T., Linhardt R. J. Detection of glycosaminoglycans as a copper(II) complex in high-performance liquid chromatography. J. Chromat. A. 1997; 787: 266–270, [CSA]
- Tokita Y., Ohshima K., Okamoto A. Degradation of hyaluronic acid during freeze drying. Polym. Degrad. Stab. 1997; 55: 159–164, [CSA]
- Tokita Y., Okamoto A. Hydrolytic degradation of hyaluronic-acid. Polym. Degrad. Stab. 1995; 48: 269–273, [CSA]
- Tool B. P. Hyaluronan in morphogenesis. Sem. Cell Devel. Biol. 2001; 12: 79–87, [CSA]
- Toole B. P., Wight T. N., Tammi M. I. Hyaluronan-cell interactions in cancer and vascular disease. J. Biol. Chem. 2002; 277: 4593–4596, [PUBMED], [INFOTRIEVE], [CSA]
- Turino G. M., Cantor J. O. Hyaluronan in respiratory injury and repair. Am. J. Respir. Crit. Care Med. 2003; 167: 1169–1175, [PUBMED], [INFOTRIEVE], [CSA]
- Turley E. A., Noble P. W., Bourguignon L. Y. W. Signaling properties of hyaluronan receptors. J. Biol. Chem. 2002; 277: 4589–4592, [PUBMED], [INFOTRIEVE], [CSA]
- Uthman I., Raynauld J. P., Haraoui B. Intra-articular therapy in osteoarthritis. Postgrad. Med. J. 2003; 79: 449–453, [PUBMED], [INFOTRIEVE], [CSA]
- Vanos H. C., Drogendijk A. C., Fetter W. P. F., Heijtink R. A., Zeilmaker G. H. The influence of contamination of culture-medium with hepatitis-B virus on the outcome of invitro fertilization pregnancies. Am. J. Obstet. Gynecol. 1991; 165: 152–159, [CSA]
- Vazquez J. R., Short B., Findlow A. H., Nixon B. P., Boulton A. J. M., Armstrong D. G. Outcomes of hyaluronan therapy in diabetic foot wounds. Diabetes Res. Clin. Pract. 2003; 59: 123–127, [PUBMED], [INFOTRIEVE], [CSA]
- Vercruysse K. P., Lauwers A. R., Demeester J. M. Absolute and empirical determination of the enzymatic-activity and kinetic investigation of the action of hyaluronidase on hyaluronan using viscosimetry. Biochem. J. 1995; 306: 153–160, [PUBMED], [INFOTRIEVE], [CSA]
- Vercruysse K. P., Prestwich G. D. Hyaluronate derivatives in drug delivery. Crit. Rev. Ther. Drug Carrier Syst. 1998; 15: 513–555, [PUBMED], [INFOTRIEVE], [CSA]
- Volpi N., Maccari F. Detection of submicrogram quantities of glycosaminoglycans on agarose gels by sequential staining with toluidine blue and Stains-All. Electrophoresis. 2002; 23: 4060–4066, [PUBMED], [INFOTRIEVE], [CSA]
- Volpi N. Hyaluronic acid and chondroitin sulfate unsaturated disaccharides analysis by high-performance liquid chromatography and fluorimetric detection with dansylhydrazine. Anal. Biochem. 2000; 277: 19–24, [PUBMED], [INFOTRIEVE], [CSA]
- Wedlock D. J., Phillips G. O., Davies A., Gormally J., Wynjones E. Depolymerization of sodium hyaluronate during freeze-drying. Int. J. Biol. Macromol. 1983; 5: 186–188, [CSA]
- Wolf J. E., Taylor J. R., Tschen E., Kang S. W. Topical 3.0% diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses. Int. J. Dermatol. 2001; 40: 709–713, [PUBMED], [INFOTRIEVE], [CSA]
- Wuthrich R. P. The proinflammatory role of hyaluronan-CD44 interactions in renal injury. Nephrol. Dial. Transplant. 1999; 14: 2554–2556, [PUBMED], [INFOTRIEVE], [CSA]
- Yerushalmi N., Arad A., Margalit R. Molecular and cellular studies of hyaluronic acid-modified liposomes as bioadhesive carriers for topical drug-delivery in wound-healing. Arch. Biochem. Biophys. 1994; 313: 267–273, [PUBMED], [INFOTRIEVE], [CSA]
- Yerushalmi N., Margalit R. Hyaluronic acid-modified bioadhesive liposomes as local drug depots: effects of cellular and fluid dynamics on liposome retention at target sites. Arch. Biochem. Biophys. 1998; 349: 21–26, [PUBMED], [INFOTRIEVE], [CSA]
- Yeung B., Marecak D. Molecular weight determination of hyaluronic acid by gel filtration chromatography coupled to matrix-assisted laser desorption ionisation mass spectrometry. J. Chromat. A 1999; 852: 573–581, [CSA]
- Yun Y. H., Goetz D. J., Yellen P., Chen W. Hyaluronan microspheres for sustained gene delivery and site-specific targeting. Biomaterials 2004; 25: 147–157, [PUBMED], [INFOTRIEVE], [CSA]
- Zhou B., Weigel J. A., Fauss L. A., Weigel P. H. Identification of the hyaluronan receptor for endocytosis (HARE). J. Biol. Chem. 2000; 275: 37733–37741, [PUBMED], [INFOTRIEVE], [CSA]
- Zhu Y. X., Granick S. Biolubrication: hyaluronic acid and the influence on its interfacial viscosity of an antiinflammatory drug. Macromolecules 2003; 36: 973–976, [CSA]